Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Fibrodysplasia ossificans progressiva (FOP) begins with very little warning. When children are born with FOP, they appear normal aside from a possibly characteristic malformation of the largest toe that…
Continue Reading
Fibrodysplasia Ossificans Progressiva: A Rare Disease That Turns The Body Into Bone
source: pixabay.com
Although many people in the United States face challenges when seeking healthcare services, new research has found that when seeking a diagnosis for a rare disease, the situation is…
Continue Reading
People Living With a Rare Disease Need Better Healthcare
source: pixabay.com
The Catawba Virginia Farmers Market’s mission is to provide the Catawba community with local produce and handicrafts. Stephanie and Donald Schneider owners of Pacaberry Farms have been vendors at the…
Continue Reading
Their Daughter’s Diagnosis: Ataxia-Telangiectasia. The Treatment: Physical Therapy, Medication, and Love
Dr. Cecilia Chung and associates at the Vanderbilt University’s Medical Center conducted a study published recently in MedPage Today. Results showed that patients who had inflammatory disorders, as well…
Continue Reading
ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity
Scientists have known for years that Wiskott-Aldrich syndrome (WAS) is caused by a gene on the X chromosome. The gene (the WASP gene) can be found throughout the immune…
Continue Reading
Researchers Discover a Therapeutic Target for Wiskott-Aldrich Syndrome
source: pixabay.com
Takeda and its collaborator, Arrowhead Pharmaceuticals, recently announced results from AROAAT-2002 of the investigational drug fazirsiran. The drug is an RNA interference therapeutic developed to lessen alpha-1 antitirypsin protein…
Continue Reading
Results From This Study are Encouraging for Alpha-1 Antitrypsin Deficiency Liver Disease
source: unsplash.com
Danielle Morley of Radcliffe, UK, has been an advocate for plasma donation ever since being diagnosed with a rare blood disorder called immune thrombocytopenic purpura (ITP) during her first…
Continue Reading
Immunoglobulin Saved Her Life and Gave Life to Her Three Children
source: pixabay.com
As time runs out, volunteer Dominic Gillen is running even harder. In an interview with KETV, he admits that they are not yet where they should be in order…
Continue Reading
Nebraskans for Medical Marijuana Are Running Out of Time to Put Petitions on the Ballot Before November
source: pixabay.com
CBC News Canada carried the story of a 23-year-old patient, Morgan Buyaki of Saskatchewan, Canada, who was diagnosed eighteen months ago with eosinophilic granulomatosis with polyangiitis (EGPA). Morgan’s mother…
Continue Reading
A Mother’s Last Hope to Save Her Daughter’s Life
source: pixabay.com
The most common form of leukemia in Western countries is chronic lymphocytic leukemia (CLL). The disease accounts for almost thirty percent of known leukemia cases. Approximately 30,000 Europeans were…
Continue Reading
Zanubrutinib Superior to Ibrutinib in Advanced CLL
A recent article at Healio Rheumatology highlights a presentation given by Dr. Arthur Kavanaugh of the University of California to attendees at the 2022 Clinical Rheumatology Congress East. Dr. Kavanaugh…
Continue Reading
A Growing List of Options for Psoriatic Arthritis Patients
Tuberous sclerosis complex (TSC) is classified as a rare genetic disorder that causes typically benign tumors in the brain, skin, heart, kidneys, or lungs. As described in a recent article…
Continue Reading
Researchers Created Mini-Kidneys to Identify Tuberous Sclerosis Complex and Solve a Medical Mystery
According to a press release by Merck & Co. issued on June 24, the European Commission has approved the use of adjuvant Pembrolizumab to treat resected stage IIB/C melanoma. "Adjuvant"…
Continue Reading
The European Commission Has Approved Pembrolizumab (Keytruda) to Treat Resected Stage IIB and IIC Melanoma
source: pixabay.com
A study of hereditary angioedema (HAE) patients in Brazil was featured in an article in the Angioedema News. Researchers found that patients waited on average seventeen years for a…
Continue Reading
Patients in Brazil Wait Decades for a Hereditary Angioedema Diagnosis
source: pixabay.com
The history of mesothelioma dates back to 1767 as being the earliest record of tumors found on the lining of the lungs. In 1909 J.G. Adami introduced the term…
Continue Reading
Mesothelioma: A Study of T-Cell Infiltration As the Disease Evolves
source: pixabay.com
Findings from the MITO23 Trial investigating the outcome of the chemotherapy drug trabectedin against physician’s choice to treat BRCA-mutated patients with ovarian cancer were presented at ASCO’s 2022 Annual…
Continue Reading
ICYMI: Trabectedin for Ovarian Cancer Did Not Meet its Primary Endpoint
source: pixabay.com
The patient, age 82, had recovered from a stroke several months ago. According to a recent article reported on dnyuz.com and originally published in the New York Times, the…
Continue Reading
ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy
source: pixabay.com
The most common gastrointestinal tumors in the world are esophageal cancers. A recent article in DovePress reports that the malignancy is also the eighth most common worldwide. In China…
Continue Reading
Study: Anlotinib as a Monotherapy for Esophageal Cancer
The study was intended to recruit 6,000 Alzheimer's patients, but even after recruiting had proceeded for seven months, just 29 patients were enrolled. As a result, the trial was cancelled,…
Continue Reading
Alzheimer’s Study Cancelled After 29 Patients Enrolled Rather Than the Anticipated 6000
source: pixabay.com
The novel program called BeginNGS™ was described in a recent article which has a goal of testing for five hundred disorders and several thousand infants. Rady Children's Institute for…
Continue Reading
New Program Evaluates the Adaptability of Precision Medicine to Identify Over 400 Genetic Disorders and Potential Treatments
Genetic testing has always been costly and directed at DNA sequencing. Only a limited number of genes could be tested. It was useful to a small number of patients…
Continue Reading
Improved Genetic Testing Brings a More Accurate Diagnosis of Primary Immunodeficiency Disorders
IBD (inflammatory bowel disease) is an umbrella term for ulcerative colitis and Crohn’s disease involving chronic inflammation in the digestive tract. Common symptoms are fatigue, pain, and reduction in appetite.…
Continue Reading
Study: H. Pylori in a New, Beneficial Role in Inflammatory Bowel Disease
Liver cirrhosis (scarring) can be fatal because damage to the liver is irreversible. A cirrhotic liver leads to liver failure, liver cancer, and eventually death. According to a report in…
Continue Reading
Patients with Liver Diseases Causing Cirrhosis May Be Predisposed to HCC
source: shutterstock.com
According to an article recently published in Targeted Oncology, the FDA approved olaparib (Lynparza), a product of AstraZeneca Pharmaceuticals, in March of this year. Lynparaza will be used as adjuvant…
Continue Reading
The FDA Approves Olaparib for BRCA-mutated HER2 Early Breast Cancer
source: pixabay.com
The medical term for an “informal caregiver” describes a person who willingly takes the responsibility to help a spouse, family member, friend, or partner. The level of care and responsibility…
Continue Reading
Cancer Commons Presents a Webinar Recording: You’re Not Alone—Validating the Caregiver Experience